Dr. Ruthee-Lu Bayer, MD

Dr. Bayer practices at Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York.

Dr. Bayer's NPI, 1215082961, was assigned on January 24, 2007. Dr. Bayer graduated from New York Medical College in 1992. Dr. Bayer holds New York license 194588.

Dr. Bayer's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center, at 450 Lakeville Rd, Lake Success, NY 11042. The practice phone is (516) 734-8281.

Dr. Bayer's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York. Dr. Bayer is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Bayer to 1 more hospital, 2 group practices and clinics, 1 clinical lab and 1 medical group, each named with a free account. Dr. Bayer's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bayer practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bayer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bayer is licensed in New York.

CMS data shows 437 Medicare services from Dr. Bayer across 4 procedure codes in 2024, for 114 Medicare patients. Medicare paid $52,294 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Dr. Bayer in 2024. The largest group is 65 to 74, with 64 patients. 70% of them have high blood pressure, and 69% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bayer's median patient age at 70, with 43% women.

In 2024, Dr. Bayer wrote 646 Medicare Part D claims for 85 patients. 85% of them were for generic drugs. CMS names the drug for 415 of them, across 14 drugs with 11 or more claims each, at $784,568 in total drug cost. In 2023, CMS named 440 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bayer for performance year 2024, reported as part of a group. Dr. Bayer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bayer as offering telehealth.

Dmand AI links 7 papers to Dr. Bayer, published from 2011 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation. Dr. Bayer's most frequent co-authors are Dennis L. Confer, MD, Mark R. Litzow, MD and Luke Paul Akard, MD.

Dmand AI links Dr. Bayer to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders.

CMS Open Payments shows 7 general payments to Dr. Bayer from 5 drug and device companies from 2017 to 2022. Consulting fees make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $3,019.

Dr. Bayer graduated from New York Medical College in 1992.